Clinical predictors of long-term efficacy of first-line pembrolizumab monotherapy in non-small cell lung cancer (NSCLC): an interim analysis of real-world data. (March 2022) - Younan, Helen-Cara; Zhang, Shuai; Monroy, Maria; Almusarhed, Manar; Julve, Max; Roy, Debashree; Toghey, Sopozme; Ahmed, Zartaj; Slater, Stephanie; Altharwane, Shaymaa; Giorgiou, Alex; Ghosh, Sharmistha; et al.